|
1
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan AT, Grégoire V, Lefebvre JL, Licitra
L, Hui EP, Leung SF and Felip E; EHNS-ESMO-ESTRO Guidelines Working
Group: Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol.
23(Suppl 7): vii83–vii85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yusuf RZ, Duan Z, Lamendola DE, Penson RT
and Seiden MV: Paclitaxel resistance: Molecular mechanisms and
pharmacologic manipulation. Curr Cancer Drug Targets. 3:1–19. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tao WY, Liang XS, Liu Y, Wang CY and Pang
D: Decrease of let-7f in low-dose metronomic paclitaxel
chemotherapy contributed to upregulation of thrombospondin-1 in
breast cancer. Int J Biol Sci. 11:48–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choi JH, Sheu JJ, Guan B, Jinawath N,
Markowski P, Wang TL and Shih IeM: Functional analysis of 11q13.5
amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel
resistance in ovarian cancer. Cancer Res. 69:1407–1415. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nagano T, Mitchell JA, Sanz LA, Pauler FM,
Ferguson-Smith AC, Feil R and Fraser P: The Air noncoding RNA
epigenetically silences transcription by targeting G9a to
chromatin. Science. 322:1717–1720. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harries LW: Long non-coding RNAs and human
disease. Biochem Soc Trans. 40:902–906. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun M, Gadad SS, Kim DS and Kraus WL:
Discovery, annotation, and functional analysis of long noncoding
RNAs controlling cell-cycle gene expression and proliferation in
breast cancer cells. Mol Cell. 59:698–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin C, Yan B, Lu Q, Lin Y and Ma L: The
role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal
carcinoma. Tumour Biol. 37:4025–4033. 2016. View Article : Google Scholar
|
|
13
|
Jiao F, Hu H, Han T, Yuan C and Wang L,
Jin Z, Guo Z and Wang L: Long noncoding RNA MALAT-1 enhances stem
cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci.
16:6677–6693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. FEBS J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21WAF1/CIP1 expression. PLoS One.
8:e772932013. View Article : Google Scholar
|
|
16
|
van der Burg ME, Vergote I, Onstenk W,
Boere IA, Leunen K, van Montfort CA and van Doorn HC: Long-term
results of weekly paclitaxel carboplatin induction therapy: An
effective and well-tolerated treatment in patients with
platinum-resistant ovarian cancer. Eur J Cancer. 49:1254–1263.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoshida K, Sanada M and Ogawa S: Deep
sequencing in cancer research. Jpn J Clin Oncol. 43:110–115. 2013.
View Article : Google Scholar
|
|
18
|
Li G, Liu Y, Su Z, Ren S, Zhu G, Tian Y
and Qiu Y: MicroRNA-324-3p regulates nasopharyngeal carcinoma
radioresistance by directly targeting WNT2B. Eur J Cancer.
49:2596–2607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S,
Deng T, Huang D, Tian Y and Qiu Y: miR-185-3p regulates
nasopharyngeal carcinoma radioresistance by targeting WNT2B in
vitro. Cancer Sci. 105:1560–1568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kong L, Zhang Y, Ye ZQ, Liu XQ, Zhao SQ,
Wei L and Gao G: CPC: Assess the protein-coding potential of
transcripts using sequence features and support vector machine.
Nucleic Acids Res. 35:W345–W349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li G, Qiu Y, Su Z, Ren S, Liu C, Tian Y
and Liu Y: Genome-wide analyses of radioresistance-associated miRNA
expression profile in nasopharyngeal carcinoma using next
generation deep sequencing. PLoS One. 8:e844862013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moulder S, Helgason T, Janku F, Wheler J,
Moroney J, Booser D, Albarracin C, Morrow PK, Atkins J, Koenig K,
et al: Inhibition of the phosphoinositide 3-kinase pathway for the
treatment of patients with metastatic metaplastic breast cancer.
Ann Oncol. 26:1346–1352. 2015.PubMed/NCBI
|
|
23
|
Cai J, Chen S, Zhang W, Zheng X, Hu S,
Pang C, Lu J, Xing J and Dong Y: Salvianolic acid A reverses
paclitaxel resistance in human breast cancer MCF-7 cells via
targeting the expression of transgelin 2 and attenuating PI3 K/Akt
pathway. Phytomedicine. 21:1725–1732. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang YY, Xie KM, Yang GQ, Mu HJ, Yin Y,
Zhang B and Xie P: The effect of glucosylceramide synthase on
P-glycoprotein function in K562/AO2 leukemia drug-resistance cell
line. Int J Hematol. 93:361–367. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li W, Tan GL, Ma YH, Peng XW and He GX:
Role of folate receptor 1 in paclitaxel-resistance of
nasopharyngeal carcinoma cells. Zhonghua Er Bi Yan Hou Tou Jing Wai
Ke Za Zhi. 45:1035–1040. 2010.In Chinese.
|
|
26
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5:e15062014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fiedler J, Breckwoldt K, Remmele CW,
Hartmann D, Dittrich M, Pfanne A, Just A, Xiao K, Kunz M, Müller T,
et al: Development of long noncoding RNA-based strategies to
modulate tissue vascularization. J Am Coll Cardiol. 66:2005–2015.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X and Xu J: Identification of
Alzheimer's disease-associated long noncoding RNAs. Neurobiol
Aging. 36:2925–2931. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Neguembor MV, Jothi M and Gabellini D:
Long noncoding RNAs, emerging players in muscle differentiation and
disease. Skelet Muscle. 4:82014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene. Sep
14–2015.Epub ahead of print. PubMed/NCBI
|
|
31
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar
|
|
33
|
Zhang W, Wang L, Zheng F, Zou R, Xie C,
Guo Q, Hu Q, Chen J, Yang X, Yao H, et al: Long noncoding RNA
expression signatures of metastatic nasopharyngeal carcinoma and
their prognostic value. Biomed Res Int. 2015:6189242015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao W, Chan JY and Wong TS: Differential
expression of long noncoding RNA in primary and recurrent
nasopharyngeal carcinoma. Biomed Res Int. 2014:4045672014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou Z, Liu H, Wang C, Lu Q, Huang Q,
Zheng C and Lei Y: Long non-coding RNAs as novel expression
signatures modulate DNA damage and repair in cadmium toxicology.
Sci Rep. 5:152932015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cheng Z, Guo J, Chen L, Luo N, Yang W and
Qu X: A long noncoding RNA AB073614 promotes tumorigenesis and
predicts poor prognosis in ovarian cancer. Oncotarget.
6:25381–25389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
